Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

A tumorsphere model of glioblastoma multiforme with intratumoral heterogeneity for quantitative analysis of cellular migration and drug response

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. A programmed wave of uridylation-primed mRNA degradation is essential for meiotic progression and mammalian spermatogenesis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Localization of urokinase-type plasminogen activator receptor on U937 cells: phorbol ester PMA induces heterogeneity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Johann Mar Gudbergsson
  • Serhii Kostrikov
  • Kasper Bendix Johnsen
  • Frederikke Petrine Fliedner
  • Christian Brøgger Stolberg
  • Nanna Humle
  • Anders Elias Hansen
  • Bjarne Winther Kristensen
  • Gunna Christiansen
  • Andreas Kjær
  • Thomas Lars Andresen
  • Meg Duroux
Vis graf over relationer

Glioblastoma multiforme (GBM) is the most common and malignant type of primary brain tumor and is characterized by its sudden onset and invasive growth into the brain parenchyma. The invasive tumor cells evade conventional treatments and are thought to be responsible for the ubiquitous tumor regrowth. Understanding the behavior of these invasive tumor cells and their response to therapeutic agents could help improve patient outcome. In this study, we present a GBM tumorsphere migration model with high biological complexity to study migrating GBM cells in a quantitative and qualitative manner. We demonstrated that the in vitro migration model could be used to investigate both inhibition and stimulation of cell migration with oxaliplatin and GBM-derived extracellular vesicles, respectively. The intercellular heterogeneity within the GBM tumorspheres was examined by immunofluorescent staining of nestin/vimentin and GFAP, which showed nestin and vimentin being highly expressed in the periphery of tumorspheres and GFAP mostly in cells in the tumorsphere core. We further showed that this phenotypic gradient was present in vivo after implanting dissociated GBM tumorspheres, with the cells migrating away from the tumor being nestin-positive and GFAP-negative. These results indicate that GBM tumorsphere migration models, such as the one presented here, could provide a more detailed insight into GBM cell biology and prove highly relevant as a pre-clinical platform for drug screening and assessing drug response in the treatment of GBM.

TidsskriftExperimental Cell Research
Udgave nummer1
Sider (fra-til)73-82
Antal sider10
StatusUdgivet - 1 jun. 2019

Bibliografisk note

Copyright © 2019 Elsevier Inc. All rights reserved.

ID: 59320616